Cargando…
Making Sense of Composite Endpoints in Clinical Research
Multiple drugs currently used in clinical practice have been approved by regulatory agencies based on studies that utilize composite endpoints. Composite endpoints are appealing because they reduce sample size requirements, follow-up periods, and costs. However, interpreting composite endpoints can...
Autores principales: | Baracaldo-Santamaría, Daniela, Feliciano-Alfonso, John Edwin, Ramirez-Grueso, Raul, Rojas-Rodríguez, Luis Carlos, Dominguez-Dominguez, Camilo Alberto, Calderon-Ospina, Carlos Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342974/ https://www.ncbi.nlm.nih.gov/pubmed/37445406 http://dx.doi.org/10.3390/jcm12134371 |
Ejemplares similares
-
Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2021) -
Definition of self-medication: a scoping review
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022) -
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022) -
Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity
por: Navarro-Navajas, Alberto, et al.
Publicado: (2022) -
Immune-related adverse events of biological immunotherapies used in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)